P
The startup has developed a medical technology platform that utilizes nanocytology to analyze cells at the nanoscale, enabling the early detection of mutations and cellular changes associated with cancer. This approach allows oncologists to identify and address the earliest signs of cancerous developments, improving treatment outcomes for patients.
Evanston, United States
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup has developed a medical technology platform that utilizes nanocytology to analyze cells at the nanoscale, enabling the early detection of mutations and cellular changes associated with cancer. This approach allows oncologists to identify and address the earliest signs of cancerous developments, improving treatment outcomes for patients.